ロード中...
A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
BACKGROUND: IgAN is the most common type of glomerulonephritis in the world. Between 15 and 40 percent of adults and children diagnosed with IgAN eventually progress to ESRD. Despite the need for effective treatment strategies, very few RCTs for IgAN have been performed. The most effective therapies...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC415550/ https://ncbi.nlm.nih.gov/pubmed/15043759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-5-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|